Semaglutide is a medication used to manage type 2 diabetes and support weight loss in people with obesity
Modern indoor, screen-heavy routines also contribute to vitamin D deficiency
Co-authored by Mohiba Tareen, MD This article was co-authored by Mohiba Tareen, MD
Orforglipron, approved under the brand name Foundayo, represents a different category of GLP-1 therapy
The Toolkit includes therapy-specific instructional content, medication administration guidance, storage and safety education, and best-practice reminders to reinforce provider-directed care
He points out that many patients currently remain on therapy for only about six months before cycling off and often switching to another treatment, creating a pattern of weight loss, regain, and repeated attempts